DE60029589D1 - Verfahren zur herstellung von azithromycin - Google Patents

Verfahren zur herstellung von azithromycin

Info

Publication number
DE60029589D1
DE60029589D1 DE60029589T DE60029589T DE60029589D1 DE 60029589 D1 DE60029589 D1 DE 60029589D1 DE 60029589 T DE60029589 T DE 60029589T DE 60029589 T DE60029589 T DE 60029589T DE 60029589 D1 DE60029589 D1 DE 60029589D1
Authority
DE
Germany
Prior art keywords
azithromycin
preparation
monohydrate
stable
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029589T
Other languages
English (en)
Other versions
DE60029589T2 (de
Inventor
Victor Centellas
Rafael Garcia
Marta Poch
Jose Diago
Johannes Ludescher
Immaculada Bosch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9915218.3A external-priority patent/GB9915218D0/en
Priority claimed from GBGB9915216.7A external-priority patent/GB9915216D0/en
Priority claimed from GBGB9930059.2A external-priority patent/GB9930059D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of DE60029589D1 publication Critical patent/DE60029589D1/de
Publication of DE60029589T2 publication Critical patent/DE60029589T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60029589T 1999-06-29 2000-06-27 Verfahren zur herstellung von azithromycin Expired - Lifetime DE60029589T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9915218.3A GB9915218D0 (en) 1999-06-29 1999-06-29 Organic compounds
GB9915218 1999-06-29
GB9915216 1999-06-29
GBGB9915216.7A GB9915216D0 (en) 1999-06-29 1999-06-29 Organic compounds
GBGB9930059.2A GB9930059D0 (en) 1999-12-20 1999-12-20 Organic compounds
GB9930059 1999-12-20
PCT/EP2000/005948 WO2001000640A1 (en) 1999-06-29 2000-06-27 Macrolides

Publications (2)

Publication Number Publication Date
DE60029589D1 true DE60029589D1 (de) 2006-09-07
DE60029589T2 DE60029589T2 (de) 2007-07-19

Family

ID=27269768

Family Applications (3)

Application Number Title Priority Date Filing Date
DE60044515T Expired - Fee Related DE60044515D1 (de) 1999-06-29 2000-06-27 Azithromycinmonohydrat
DE20023815U Expired - Lifetime DE20023815U1 (de) 1999-06-29 2000-06-27 Azithromycin enthaltende Zusammensetzungen
DE60029589T Expired - Lifetime DE60029589T2 (de) 1999-06-29 2000-06-27 Verfahren zur herstellung von azithromycin

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE60044515T Expired - Fee Related DE60044515D1 (de) 1999-06-29 2000-06-27 Azithromycinmonohydrat
DE20023815U Expired - Lifetime DE20023815U1 (de) 1999-06-29 2000-06-27 Azithromycin enthaltende Zusammensetzungen

Country Status (10)

Country Link
US (1) US6703372B1 (de)
EP (2) EP1712556B1 (de)
JP (2) JP4703924B2 (de)
KR (1) KR100700475B1 (de)
AT (2) ATE334136T1 (de)
AU (1) AU5820400A (de)
DE (3) DE60044515D1 (de)
ES (2) ES2346782T3 (de)
HR (1) HRP20010956B1 (de)
WO (1) WO2001000640A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6528492B1 (en) 2000-07-25 2003-03-04 Instituto De Investigacion En Quimica Aplicada S.C. Single-step process for preparing 7, 16-deoxy-2-aza-10-0-cladinosil-12-0-desosaminil-4, 5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1) hexadeca-1(2)-en-ona and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
ES2172417B1 (es) * 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
PL207076B1 (pl) * 2000-11-27 2010-10-29 Sandoz Ag Sposób wytwarzania jednowodzianu azytromycyny
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
PT1390377E (pt) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova forma cristalina da azitromicina
EP1671978A1 (de) * 2001-05-22 2006-06-21 Pfizer Products Inc. Neue Kristallforme von Azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1455757A2 (de) * 2001-12-21 2004-09-15 Pfizer Products Inc. Verfahren zur feuchtgranulierung von azithromycin
CN1639181A (zh) * 2002-02-26 2005-07-13 明治制果株式会社 新的15元环氮杂内酯及新的16元环二氮杂内酯衍生物及其制备方法
JP2005522470A (ja) * 2002-04-03 2005-07-28 ハンミ ファーム． シーオー．， エルティーディー． アジスロマイシンの製造方法及びそれに用いられる９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンＡの結晶性水和物
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1648473B1 (de) * 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Schnellösliches azithromycin in einzeldosisform
US20060189800A1 (en) * 2003-07-24 2006-08-24 Mitsuru Ohkubo Indolopyrrolocabazole derivative and antitumor agent
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP2008520686A (ja) * 2004-11-17 2008-06-19 スミスクライン・ビーチャム・コーポレイション 新規な抗菌化合物の使用
CN101177441B (zh) * 2007-12-05 2012-05-23 浙江耐司康药业有限公司 一种稳定的阿奇霉素一水合物结晶的制备方法
CN101445532B (zh) * 2008-12-30 2011-09-21 广东东阳光药业有限公司 阿奇霉素一水合物结晶的制备方法
JP2012520268A (ja) 2009-03-13 2012-09-06 ダ・ボルテラ グラム陰性細菌の除去のための組成物及び方法
CN102417531B (zh) * 2011-12-20 2014-06-11 浙江国邦药业有限公司 一种阿奇霉素一水合物的制备方法
CN105030704B (zh) * 2015-06-29 2018-09-07 石药集团欧意药业有限公司 阿奇霉素片剂及其制备方法
CN110684056B (zh) * 2018-07-05 2021-07-13 青岛农业大学 一种阿奇霉素中间体的化学合成方法
CN114516895A (zh) * 2020-11-19 2022-05-20 江苏威奇达药业有限公司 一种阿奇霉素胺结晶方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
GB9705323D0 (en) 1997-03-14 1997-04-30 Biochemie Sa Organic compounds
ATE269350T1 (de) * 1997-07-08 2004-07-15 Biochemie Sa Solvate von erythromycin a oxim
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
GB9824580D0 (en) * 1998-11-10 1999-01-06 Biochemie Sa Organic compounds

Also Published As

Publication number Publication date
DE60044515D1 (de) 2010-07-15
DE60029589T2 (de) 2007-07-19
ES2346782T3 (es) 2010-10-20
EP1712556A1 (de) 2006-10-18
JP4703924B2 (ja) 2011-06-15
JP2003503417A (ja) 2003-01-28
ATE334136T1 (de) 2006-08-15
WO2001000640A1 (en) 2001-01-04
US6703372B1 (en) 2004-03-09
ATE469910T1 (de) 2010-06-15
KR20020016862A (ko) 2002-03-06
DE20023815U1 (de) 2006-06-08
JP2011126894A (ja) 2011-06-30
AU5820400A (en) 2001-01-31
KR100700475B1 (ko) 2007-03-28
EP1189915B1 (de) 2006-07-26
EP1712556B1 (de) 2010-06-02
EP1189915A1 (de) 2002-03-27
ES2267549T3 (es) 2007-03-16
HRP20010956A2 (en) 2003-08-31
HRP20010956B1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
DE60029589D1 (de) Verfahren zur herstellung von azithromycin
DE60009578D1 (de) Vorrichtung zur Herstellung von Kontaktkörpern
DE60043850D1 (de) Verfahren zur herstellung von absorbierenden artikeln
DE69837681D1 (de) Verfahren zur herstellung von 1,3-diolen
DE69932609D1 (de) Verfahren zur herstellung von 1-chloro-1,1,3,3,3-pentafluorpropan
DE60012865D1 (de) Entspiegelungsfilm, Verfahren zur Herstellung des Entspiegelungsfilms und Entspiegelungsglas
DE60134344D1 (de) Verfahren zur herstellung von anagrelid
DE59912242D1 (de) Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan
DE60022996D1 (de) Verfahren zur herstellung von poly(1,4-cyclohexandicarboxylat)
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE69936449D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE60220658D1 (de) Verfahren zur produktion von 2,6-dihalogenopurinen
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE50000074D1 (de) Verfahren zur Herstellung von halogenierten 1,2-Disilaethanen
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE60002254T2 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
DE69920003D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
ATE267839T1 (de) Verfahren zur herstellung von cyclo-(asp-dphe- nmeval-arg-gly)
DE60025096D1 (de) Verfahren zur herstellung von n,n'-dialkylalkandiaminen
DE60036341D1 (de) Verfahren zur Herstellung von bedruckten Artikeln
ATE281437T1 (de) Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole
DE59900401D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4-carboxylat
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN